Clinical trial
Botulinum Toxin for the Treatment of Involuntary Movement Disorders
NCT00001208 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Recruiting
Key facts
| NCT number | NCT00001208 |
|---|---|
| Title | Botulinum Toxin for the Treatment of Involuntary Movement Disorders |
| Official title | Botulinum Toxin for the Treatment of Neurological Disorders |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Movement Disorders |
| Enrollment | 2,000 |
| Start date | Oct 26, 1989 |
| First posted | Nov 4, 1999 |
| Last update posted | Dec 31, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: